Teodoro Piliego
Teodoro Piliego publishes mostly in Surgery, Pharmacology and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Pharmacology and Obesity Treatment and Cancer, Lipids, and Metabolism.
- World rank
- #6,318,035 of 7,710,434 ranked researchers
- Rank in Italy
- #208,238 of 242,206
- Works
- 17
- Citations
- 270
- Citations per work
- 15.9
What does Teodoro Piliego research?
Teodoro Piliego's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1269.9%
- Medicine1269.9%
- Life Sciences420.9%
- Everything else29.2%
- 1Surgery23% of their works
- 2Pharmacology16% of their works
- 3Cardiology and Cardiovascular Medicine16% of their works
- 4Endocrinology, Diabetes and Metabolism14% of their works
- 5Molecular Biology12% of their works
- 6Cancer Research9% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Pharmacology and Obesity Treatment
- Cancer, Lipids, and Metabolism
- Peroxisome Proliferator-Activated Receptors
- Diabetes Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Lipid metabolism and disorders
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Teodoro Piliego's research?
The keywords of their largest research topics: Clinical Trials, Statins, Obesity, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Diabetes and Pharmacotherapy.
- Insulin Resistance
- Cardiovascular Disease
- ANGPTL3
- Peroxisome Proliferator-Activated Receptors
- Lipid Metabolism
- Cardiovascular Outcomes
- Atherosclerosis
- Pharmacotherapy
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Clinical Trials
- Obesity
- Cholesterol-lowering
- Diabetes
- Weight Loss
- Metabolic Syndrome
- Fatty Acid Synthase
- PPARs
- Type 2 Diabetes
- Aspirin
- Clopidogrel
- Lipoprotein Lipase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Clinical Trials132 topics
- Statins112 topics
- Obesity103 topics
- Cardiovascular Disease Prevention81 topic
- Cholesterol-lowering81 topic
- Cholesterol52 topics
- Diabetes52 topics
- Pharmacotherapy51 topic
- Weight Loss51 topic
- Atherosclerosis42 topics
- Metabolic Syndrome42 topics
- Cardiovascular Outcomes31 topic
- Fatty Acid Synthase31 topic
- Lipid Metabolism31 topic
- PPARs31 topic
- Peroxisome Proliferator-Activated Receptors31 topic
- Type 2 Diabetes31 topic
- ANGPTL321 topic
- Aspirin21 topic
- Cardiovascular Disease21 topic
- Clopidogrel21 topic
- Insulin Resistance21 topic
- Lipoprotein Lipase21 topic
Where does Teodoro Piliego work?
Teodoro Piliego's main affiliation in the publication record is Environment Park, Italy.
How many publications and citations does Teodoro Piliego have?
OpenAlex counts 17 works and 270 citations for Teodoro Piliego, an h-index of 9, ranking #6,318,035 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Teodoro Piliego. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.